Peptide transport in antigen presentation

Current Opinion in Hematology

Volumn 3, Issue 1, 1996, Pages 19-26

  Marusina, Kate ^a   Monaco, John J ^a,b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CARRIER PROTEIN;

ANTIGEN PRESENTATION; BINDING AFFINITY; HUMAN; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TRANSPORT; REVIEW;

EID: 0029936183     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199603010-00004     Document Type: Review

References (92)

1. Engelhard VH: Structure of peptides associated with MHC class I molecules. Curr Opinion Immunol 1994, 6:13-23.
2. Rotzschke O, Falk K: Naturally occurring peptide antigens derived from the MHC class-I-restricted processing pathway. Immunol Today 1991, 12:447-455.
3. Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee HG: Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991, 351:290-296.
4. Monaco JJ, Cho S, Attaya M: Transport protein genes in the murine MHC: possible implications for antigen processing. Science 1990, 250:1723-1726.
5. Martinez CK, Monaco JJ: Homology of proteasome subunits to a major histocompatibility complex linked LMP gene. Nature 1991, 353:664-667.
6. Deverson EV, Gow ER, Coadwell WJ, Monaco JJ, Butcher GW, Howard JC: MHC class II region encoding proteins related to the multidrug resistance family of membrane transporters. Nature 1990, 348:738-741.
7. Trowsdale J, Hanson I, Mockridge I, Beck S, Townsend A, Kelly A: Sequences encoded in the class II region of the MHC related to the "ABC" superfamily of transporters. Nature 1990, 348:741-744.
8. Attaya M, Jameson S, Martinez CK, Hermel E, Aldrich C, Forman J, Lindahl KF, Bevan MJ, Monaco JJ: Ham-2 corrects the class I antigen-processing defect in RMA-S cells. Nature 1992, 355:647-649.
9. Aldrich CJ, Waltrip R, Hermel E, Attaya M, Lindahl KF, Monaco JJ, Forman J: T cell recognition of Qa-1b antigens in cells lacking a functional transporter. J Immunol 1992, 149:3773-3777.
10. Aldrich CJ, DeCloux A, Woods AS, Cotter RJ, Soloski MJ, Forman J: Identification of a TAP-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen. Cell 1994, 79:649-658.
11. Tabaczewski P, Stroynowski I: Expression of secreted and glycosylphosphatidylinositol-bound Qa-2 molecules is dependent on functional TAP-2 peptide transporter. J Immunol 1994, 152:5268-5274.
12. Hanau D, Fricker D, Bieber T, Esposito-Farese M-E, Bausinger H, Cazenave J-P, Donato L, Tongio M-M, de la Salle H: CD1 expression is not affected by human peptide transporter deficiency. Hum Immunol 1994, 41:61-68.
13. Kleijmeer MJ, Kelly A, Geuze HJ, Slot JW, Townsend A, Trowsdale J: Location of MHC-encoded transporters in the endoplasmic reticulum and cis-Golgi. Nature 1992, 357:342-344.
14. Driscoll J, Brown MG, Finley D, Monaco JJ: MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature 1993, 365:262-264.
15. 2-microglobulin complexes associate only with TAP1, not with TAP2.
16. Androlewicz MJ, Cresswell P: Human transporters associated with antigen processing possess a promiscuous peptide-binding site. Immunity 1994, 1:7-14. First demonstration of ATP-independent peptide-binding site on TAP. Peptides of varying length and sequence were assayed for their ability to compete for transport with an iodinated reference peptide. TAP shows increased selectivity for longer peptides.
17. Spies T, Cerundolo V, Colonna M, Cresswell P, Townsend A, DeMars R: Presentation of viral antigen by MHC class I molecules is dependent on putative peptide transporter heterodimer. Nature 1992, 355:644-646.
18. Kelly A, Powis S, Kerr L-A, Mockridge I, Elliot T, Bastin J, Uchanska-Ziegler B, Ziegler A, Trowsdale J, Townsend A: Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex. Nature 1992, 355:641-644.
19. Muller K, Ebensperger C, Tampe R: Nucleotide binding to the hydrophilic C terminal domain of the transporter associated with antigen processing (TAP). J Biol Chem 1994, 19:14032-14037. The purified recombinant nucleotide-binding domain of TAP1 specifically binds to ATP and ATP analogues. However, ATP hydrolysis by TAP1 nucleotide-binding domain is not detected. These experiments support the theory of TAP-dependent peptide translocation.
20. Neefjes JJ, Momburg F, Hämmerling GJ: Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science 1993, 261:769-771.
21. Van Endert PM, Tampe R, Meyer TH, Tisch R, Bach J-F, McDevitt HO: A sequential model for peptide binding and transport by the transporters associated with antigen processing. Immunity 1994, 1:491-500. Characterization of TAP overexpression system in Sf9 cells demonstrates that TAPs are able to bind peptides in the absence of ATP and only when both TAP1 and TAP2 are present. Binding of ATP releases peptide from TAP peptide-binding site. Release of peptides from microsomes is ATP, pH, and temperature dependent.
22. Baurkowitz T, Hwang TC, Nairn AC, Gatsby DC: Coupling of CFTR CI-channel gating to an ATP hydrolysis cycle. Neuron 1994, 12:473-482.
23. Anderson MP, Welsh MJ: Regulation by ATP and ADP of CFTR chloride channels that contain mutant nucleotide-binding domains. Science 1992, 257:1701-1703.
24. Hwang TC, Nagel G, Nairn AC, Gatsby DC: Regulation of the gating of cystic fibrosis transmembrane conductance regulator CI channel by phosphorylation and ATP hydrolysis. Proc Natl Acad Sci U S A 1994, 91:4698-4702.
25. Gunderson KL, Kopito R: Effects of pyrophosphate and nucleotide analogs suggest a role for ATP hydrolysis in cystic fibrosis transmembrane regulator channel gating. J Biol Chem 1994, 269:19349-19353.
26. Shimabuku AM, Nishimoto T, Ueda K, Komano T: P-glycoprotein. ATP hydrolysis by the N-terminal nucleotide-binding domain. J Biol Chem 1992, 267:4308-4311.
27. Schumacher TNM, Heemels M-T, Neefjes JJ, Kast WM, Melief CJM, Ploegh H: Direct binding of peptides to empty MHC class I molecules on intact cells and in vitro. Cell 1990, 62:563-567.
28. Ortiz-Navarette V, Hämmerling GJ: Surface appearance and instability of empty H-2 class I molecules under physiological conditions. Proc Natl Acad Sci U S A 1991, 88:3594-3597.
29. Sijts AJAM, Ossendorp F, Mengede EAM, van den Elsen PJ, Melief CJM: Immunodominant mink cell focus-inducing murine leukemia virus (MuLV)-encoded CTL epitope, identified by its MHC class I-binding motif, explains MuLV-type specificity of MCF-directed cytotoxic T lymphocytes. J Immunol 1994, 152:106-116.
30. Sijts, AJAM, De Bruijn, MLH, Nieland, JD, Kast, WM, Melief, CJM: Cytotoxic T lymphocytes against the antigen-processing-defective RMA-S tumor cell line. Eur J Immunol 1992, 22:1639-1642.
31. Zhou N, Glass R, Momburg F, Hämmerling GJ, Jondal M, Ljunggren H-G: TAP2-defective RMA-S cells present Sendai virus antigen to cytotoxic T lymphocytes. Eur J Immunol 1993, 23:1796-1801.
32. Ossevoort MA, Sijts AJAM, van Veen KJH, Momburg F, Hämmerling GJ, Butcher GW, Howard JC, Kast WM, Melief CJM: Differential effect of transporter Tap2 gene introduction into RMA-S cells on viral antigen processing. Eur J Immunol 1993, 23:3082-3088.
33. Esquivel F, Yewdell J, Bennink J: RMA/S cells present endogenously synthesized cytosolic proteins to class I restricted cytotoxic T lymphocytes. J Exp Med 1992, 175:163-168.
34. Gabathuler R, Reid G, Kolaitis G, Driscoll J, Jefferies WA: Comparison of cell lines deficient in antigen processing reveals a functional role for TAP-1 alone in antigen processing. J Exp Med 1994, 180:1415-1425. CMT.64, a small-lung carcinoma cell line, does not express TAP1/2 unless treated with gamma interferon. Uninduced CMT.64, infected with vesicular stomatitis virus is not recognized by specific cytotoxic T lymphocytes. Introduction of rat TAP1 gene in CMT.64 restores cytotoxic T-lymphocyte recognition of infected cells, indicating possible involvement of TAP1 homodimer in peptide translocation.
35. Hosken NA, Bevan MJ: An endogenous antigenic peptide bypasses the class I antigen presentation defect in RMA-S. J Exp Med 1992, 175:719-729.
36. Aosai F, Ohlen C, Ljunggren HG, Hoglund P, Franksson L, Ploegh H, Townsend A, Kärre K, Strauss HJ: Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells. Eur J Immunol 1991, 21:2767-2774.
37. Ljunggren H-G, van Kaer L, Ploegh HL, Tonegawa S: Altered natural killer cell repertoire in Tap-1 mutant mice. Proc Natl Acad Sci U S A 1994, 91:6520-6524.
38. + T cells. Cell 1992, 71:1205-1214.
39. + T cells are present in low but significant numbers and retain cytotoxicity. The sibling who suffered the most from recurrent respiratory infections also showed an increase in double-positive T cells and γδ T cells.
40. + T cells in Tap-1 mutant mice. Proc Natl Acad Sci U S A 1994, 91:6525-6528.
41. + T cells in TAP1 mutant mice by human β2-microglobulin transgene. J Exp Med 1995, 181:787-792.
42. Liu T, Zhou X, Orvell C, Lederer E, Ljunggren H-G, Jondal M: Heat inactivated Sendai virus can enter multiple MHC class I processing pathways and generate cytotoxic T lymphocyte responses in vivo. J Immunol 1995, 154:3147-3155.
43. Braud V, Chevrier D, Cesbron A, Bignon J-D, Kaplan C, Valentin N, Muller JY: Susceptibility to autoimmunization to platelet HPA-1a antigen involves TAP1 polymorphism. Hum Immunol 1994, 41:141-145.
44. Momburg F, Neefjes JJ, Hämmerling G: Peptide selection by MHC-encoded TAP transporters. Curr Opin Immunol 1994, 6:32-37.
45. Neefjes JJ, Gottfried E, Roelse J, Gromme M, Obst R, Hämmerling GJ, Momburg F: Analysis of the fine specificity of rat, mouse and human TAP peptide transporters. Eur J Immunol 1995, 25:1133-1136. Along with the study by Momburg et al. (Nature 1994, 367:648-651), this paper analyzes the effect of amino acid variation at the N- and C-termini and positions 2 to 7 of substrate peptides on TAP-mediated transport in streptolysin O-permeabilized cells and in microsomes. Only a few amino acids in internal positions significantly influence peptide transport. The C-terminal residue is the predominant determinant of species and substrate specificity.
46. Momburg F, Roelse J, Howard JC, Butcher GW, Hämmerling G, and Neefjes JJ: Selectivity of MHC-encoded peptide transporters from human, mouse and rat. Nature 1994, 367:648-651. Along with the study by Neefjes et al. (Eur J Immunol 1995, 25:1133-1136), this paper analyzes the effect of amino acid variation at the N- and C-termini and positions 2 to 7 of substrate peptides on TAP-mediated transport in streptolysin O-permeabilized cells and in microsomes. Only a few amino acids in internal positions significantly influence peptide transport. The C-terminal residue is the predominant determinant of species and substrate specificity.
47. a.
48. g7 (NOD/Lt) haplotype translocate similar sets of peptides. Proc Natl Acad Sci U S A 1994, 91:13004-13008.
49. Gaczynska M, Rock KL, Goldberg AL: Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 1993, 365:264-267.
50. van Endert PM, Riganelli D, Greco G, Fleischhauer K, Sidney J, Sette A, Bach J-F: The peptide binding motif for the human transporter associated with antigen processing. J Exp Med 1995, in press.
51. Neisig A, Roelse J, Sijts AJAM, Ossendorp F, Feltkamp MCW, Kast WM, Melief CJM, Neefjes JJ: Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I presentable peptides and the effect of flanking sequences. J Immunol 1995, 154:1273-1279.
52. Schumacher TNM, Kantesaria DV, Heemels M-T, Ashton-Rickardt PG, Shepherd JC, Fruh K, Yang Y, Peterson P, Tonegawa S, Ploegh H: Peptide length and specificity of the mouse TAP1/TAP2 translocator. J Exp Med 1994, 179:533-540.
53. Robbins PA, Lettice LA, Rota P, Santos-Aguado J, Rothbard J, McMichael AJ, Strominger JL: Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations within HLA A2. J Immunol 1989, 143:4098-4103.
54. Parker KC, Carreno BM, Sestak L, Utz U, Biddison WE, Colligan JE: Peptide binding to HLA-A2 and HLA-B27 isolated from Escherichia coli. Reconstitution of HLA-A2 and HLA-B27 heavy chain/beta 2-microglobulin complexes requires specific peptides. J Biol Chem 1992, 267:5451-5459.
55. Cerundolo V, Elliot T, Elvin J, Bastin J, Rammensee H-G, Townsend A: The binding affinity and dissociation rates of peptides for class I major histocompatibllity complex molecules. Eur J Immunol 1991, 21:2069-2075.
56. Urban RG, Chicz RM, Lane WS, Strominger JL, Rehm A, Kenter MJH, UytdeHaag CM, Ploegh H, Uchanska-Ziegler B, Ziegler A: A subset of HLA-B27 molecules contains peptides much longer than nonamers. Proc Natl Acad Sci U S A 1994, 91:1534-1538. A subset of HLA-B27 molecules binds peptides up to 33 amino acid residues in length. Peptide transporter is required for delivery of these long peptides to HLA-B27.
57. Collins EJ, Garboczi DN, Wiley DC: Three dimensional structure of a peptide extending from one end of a class I MHC binding site. Nature 1994, 371:626-629.
58. b) associated with unusually long peptides: implications for antigen processing and presentation. Proc Natl Acad Sci U S A 1994, 91:4145-4149.
59. Shepherd JC, Schumacher TNM, Ashton-Rickardt PG, Imaeda S, Ploegh HL, Janeway CA Jr, Tonegawa S: TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective. Cell 1993, 745:577-584.
60. Momburg F, Roelse J, Hämmerling GJ, Neefjes JJ: Peptide size selection by the major histocompatibility complex-encoded peptide transporter. J Exp Med 1994, 179:1613-1623. As determined by Edman degradation of translocated peptides, TAP selects for peptides with the size range that covers the length of peptides associated with class I molecules. Longer peptides may also be transported, but some require prior trimming in cytosol.
61. Roelse J, Gromme M, Momburg F, Hämmerling G, Neefjes J: Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling. J Exp Med 1994, 180:1591-1597. Peptides that fail to bind to class I molecules are slowly trimmed in endoplasmic reticulum. Peptides released from the endoplasmic reticulum are rapidly degraded in the cytosol. A fraction of peptides that escape degradation recycle back to the endoplasmic reticulum in a TAP-dependent fashion.
62. Falk K, Rotzschke O, Rammensee H-G: Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature 1990, 348:248-251.
63. Powis SJ, Tonks S, Mockridge I, Kelly A, Bodmer J, Trowsdale J: Alleles and haplotypes of the MHC-encoded ABC transporters TAP1 and TAP2. Immunogenetics 1993, 37:373-380.
64. Colonna M, Bresnahan M, Bahram S, Strominger JL, Spies T: Allelic variants of the human putative peptide transporter involved in antigen processing. Proc Natl Acad Sci U S A 1992, 89:3932-3936.
65. Powis SJ, Deverson EV, Coadwell WJ, Cruela A, Huskisson NS: Effect of polymorphism of an MHC linked transporter on the peptides assembled in a class I molecule. Nature 1992, 357:211-215.
66. Heemels M-T, Schumacher TNM, K Wonigeit, HL Ploegh: Peptide translocation by variants of the transporter associated with antigen processing. Science 1993, 262:2059-2063.
67. Androlewicz MJ, Anderson KS, Cresswell P: Evidence that transporters associated with antigen-processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proc Natl Acad Sci U S A 1993, 90:9130-9134.
68. Moins-Teisserenc H, Semana G, Alizadeh M, Loiseau P, Bobrynina V, Deschamps I, Edan G, Birebent B, Genetet B, Sabouraud O, Charron D: TAP2 gene polymorphism contributes to genetic susceptibility to multiple sclerosis. Hum Immunol 1995, 42:195-202.
69. Kellar-Wood HF, Powis SH, Gray J, Compson DAS: MHC-encoded TAP1 and TAP2 dimorphisms in multiple sclerosis. Tissue Antigens 1994, 43:129-132.
70. Lofti M, Sastry A, Ye M, Van der Meulen J, Dosch HM, Singal DP: HLA-DQ and TAP2 genes in patients with insulin-dependent diabetes mellitus. Immunol Lett 1994, 41:201-204.
71. Nakanishi K, Kobayashi T, Murase T, Kosaka K: Lack of association of the transporter associated with antigen processing with Japanese insulin-dependent diabetes mellitus. Metabolism 1994, 43:1013-1017.
72. van Endert PM, Liblau RS, Patel SD, Fugger L, Lopez T, Pociot F, Nerup J, McDevitt H: Major histocompatibility complex-encoded antigen processing gene polymorphism in IDDM. Diabetes 1994, 43:110-117.
73. Djilali-Saiah I, Caillat-Zucman S, Schmitz J, Caves-Vieira ML, Bach JF: Polymorphism in antigen processing (TAP, LMP) and HLA class II genes in cellac disease. Hum Immunol 1994, 40:8-16.
74. Tighe R, Hall MA, Cardi E, Ashkenazi M, Lanchbury JS, Ciclitira P: Association between alleles of the major histocompatibility complex-encoded ABC transporter gene TAP2, HLA class II alleles, and celiac disease susceptibility. Hum Immunol 1994, 39:9-16.
75. Ploski R, Undlien DE, Vinjie O, Forre O, Thorsby E, Ronningen K: Polymorphism of human major histocompatibility complex-encoded transporter associated with antigen processing (TAP) genes and susceptibility to juvenile rheumatoid arthritis. Hum Immunol 1994, 39:54-60.
76. Middleton D, Megaw G, Cullen C, Hawkins S, Darke C, Savage D: TAP1 and TAP2 polymorphism in multiple sclerosis patients. Hum Immunol 1994, 40:131-134.
77. Spurkland A, Knutsen I, Undlien DE, Vartdal F: No association of multiple sclerosis to alleles at the TAP2 locus. Hum Immunol 1994, 39:299-301.
78. Fakler J, Schmitt-Egenolf M, Vejbaesya S, Boehncke W-H, Sterry W, Eiermann TH: Analysis of TAP2 and HLA-DP gene polymorphism in psoriasis. Hum Immunol 1994, 40:299-302.
79. Burney RO, Pile KD, Gibson K, Calin A, Kennedy L,G, Sinnott PJ, Powis SH, Wordsworth BP: Analysis of the MHC class II encoded components of the HLA class I antigen processing pathway in ankylosing spondylitis. Ann Rheum Dis 1994, 53:58-60.
80. Martinez-Laso J, Martin-Villa JM, Alvarez M, Martinez-Quiles N, Uedo G, Amaiz-Villena A: Susceptibility to insulin-dependent diabetes mellitus and short cytoplasmic ATP-binding domain TAP2·01 alleles. Tissue Antigens 1994, 44:184-188.
81. Caillat-Zucman S, Bertin E, Timsit J, Boitard C, Assan R, Bach J-F: Protection from insulin dependent diabetes mellitus is linked to a peptide transporter gene. Eur J Immunol 1993, 23:1784-1788.
82. Neefjes JJ, Hämmerling GJ, Momburg F: Folding and assembly of MHC class I heterodimers in the endoplasmic reticulum of intact cells precedes the binding of peptide. J Exp Med 1993, 178:1971-1980.
83. 2-microglobulin complexes.
84. 2-microglobulin complexes could be coimmunoprecipitated, using anti-TAP or anti-class I antibodies. TAP/class I association could be disrupted by addition of class I binding peptides. These data suggest that association of TAP with class I molecules may promote an efficient peptide capturing by the latter.
85. Bacik I, Cox JH, Anderson R, Yewdell JW, Bennink JR: TAP (Transporter associated with antigen processing)-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino but not carboxyl-terminus of the peptide. J Immunol 1994, 152:381-387.
86. Anderson K, Cresswell P, Gammon M, Hermes J, Williamson A, Zweerink H: Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell mediated lysis. J Exp Med 1991, 174:489-492.
87. Grandea AG, Androlewicz MJ, Raghbir SA, Geraghty DE, Spies T: Dependence of peptide binding by MHC class I molecules on their interaction with TAP peptide transporters. Science 1995, 270:105-108.
88. Hill A, Judovic P, York I, Russ G, Bennink J, Yewdell J, Ploegh H, Johnson D: Herpes simplex virus turns off the TAP to evade host immunity. Nature 1995, 375:411-415. Along with the paper by Fruh et al. (Nature 1995, 375:415-418), this paper provides evidence that cytoplasmic protein ICP47 of herpes simplex virus interferes with loading of class I molecules by direct binding to TAP and inhibition of peptide translocation.
89. Fruh K, Ahn K, Djaballah H, Sempe P, van Endert PM, Tampe R, Peterson PA, Yang Y: A viral inhibitor of peptide transporters for antigen presentation. Nature 1995, 375:415-418. Along with the paper by Hill et al. (Nature 1995, 375:411-415), this paper provides evidence that cytoplasmic protein ICP47 of herpes simplex virus interferes with loading of class I molecules by direct binding to TAP and inhibition of peptide translocation.
90. Flynn GC, Pohl J, Flocco MT, Rothman JE: Peptide-binding specificity of the molecular chaperone BIP. Nature 1991, 353:726-730.
91. Li Z, Srivastava PK: Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation. EMBO J 1993, 12:3143-3151.
92. Malarkannan S, Goth S, Buchholz DR, Shastri N: The role of MHC class I molecules in the generation of endogenous peptide/MHC complexes. J Immunol 1995, 154:585-598.